抗血栓薬を継続服用している患者におけるEGDおよび大腸内視鏡検査後の出血率

基本情報

NCT ID

NCT02594813

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

10,000

治験依頼者名

Showa Inan General Hospital

概要

The bleeding rate of both EGD (including biopsy) and colonoscopy (including biopsy, cold or hot snare polypectomy, or EMR) in patients who continue to take various antithrombotic drugs is studied prospectively. The immediate or delayed bleeding that requires hemostatic clipping or other endoscopic treatments is defined as the bleeding. Immediate bleeding requiring hemostatic clipping is defined as spurting or oozing which continued for more than 30 seconds. Delayed bleeding is defined as bleeding that requires the endoscopic treatment within 2 weeks after endoscopy. Prophylactic clipping is not performed after taking biopsy and doing polypectomy. Additionally, investigators evaluate the rate of injured submucosal arteries of the excised specimen when the bleeding occurs.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)